Press Releases 2014

SANOFI : Merial acquires two major equine health products from Bayer

Sanofi : Merial acquires Merck manufacturing facility in Barceloneta, Puerto Rico

Sanofi : European CHMP Adopts Positive Opinion for Genzyme's Cerdelga® (eliglustat) Capsules

Sanofi : Sanofi and Regeneron Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis

Sanofi : Sanofi Outlines Next Wave of Innovative Medicines and Vaccines

Sanofi : Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

Sanofi : Sanofi nominates Professor Bonnie L. Bassler to its Board of Directors

Sanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator

Sanofi : Genzyme's Lemtrada Approved by the FDA

Sanofi : Sanofi and the Institut Pasteur reward four researchers for their influential work in the life sciences

SANOFI : Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma

Press Release : Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis - Tuesday November 4

The New England Journal of Medicine Publishes Results of Final Landmark Phase III Efficacy Clinical Study of Sanofi Pasteur's Dengue Vaccine Candidate

Statement from Sanofi Board of Directors

SANOFI : Board Composition of Sanofi

Sanofi delivers Business EPS(1) growth of 10.3% at CER in Q3 2014

SANOFI : Information concerning the total number of voting rights and shares

Sanofi : Sanofi and Regeneron Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis

Sanofi Pasteur and Immune Design Collaborate on a Vaccine to Treat Herpes Simplex Virus

Sanofi : Shantha's Investigational Rotavirus Vaccine Enters Phase III Clinical Trials in India

Sanofi : Pre-quarterly Results Communication

Sanofi and Regeneron Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps

Sanofi : Information concerning the total number of voting rights and shares

Sanofi : Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

Sanofi : At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme's Lemtrada in Pivotal Studies

Sanofi : Sanofi successfully prices EUR 3 billion bond issue

Sanofi Pasteur's Dengue Vaccine Candidate Successfully Completes Final Landmark Phase III Clinical Efficacy Study in Latin America

Sanofi : Information concerning the total number of voting rights and shares

Sanofi and Regeneron Present Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

SANOFI Sanofi and Regeneron to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

SANOFI : FDA Approves Genzyme's Cerdelga(TM) (eliglustat) Capsules

SANOFI : Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine

Sanofi : First antimalarial treatments produced with semisynthetic artemisinin enter market

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin

Sanofi: Online Availability of Sanofi Group's Half-Year Financial Report for 2014

SANOFI: Solid sales and Business EPS(1) growth at CER in Q2 2014

Sanofi and Regeneron Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

Sanofi : Information concerning the total number of voting rights and shares

Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States

Sanofi : First Ever Dengue Vaccine Candidate To Show Efficacy Against Dengue Fever and Dengue Haemorrhagic Fever in Asia

Sanofi :Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis

FDA Accepts Sanofi's New Drug Application for Basal Insulin Toujeo®

Sanofi : Pre-quarterly Results Communication

SANOFI : Information concerning the total number of voting rights and shares

Sanofi Reports Positive Phase 3 Results for Toujeo®

Sanofi and Medtronic to Form Strategic Alliance in Diabetes to Improve Patient Experience and Outcomes

Sanofi and Regeneron Announce New, Detailed Data from Positive Sarilumab Phase 3 Rheumatoid Arthritis Trial at EULAR:

Genzyme's Lemtrada Resubmission Accepted for Review by FDA

Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...

Sanofi: Annual General Shareholder Meeting of May 5, 2014

Shantha's Pentavalent Pediatric Vaccine prequalified by World Health Organization

Sanofi: Slowing of Brain Atrophy and Reductions in New MS Lesions Sustained at Three Years in Patients Treated with Genzyme's Lemtrada

SANOFI: Q1 2014 Business EPS(1) up 5.8% at CER

The World's First, Large-Scale Dengue Vaccine Efficacy Study Successfully Achieved Its Primary Clinical Endpoint

The World's First, Large-Scale Dengue Vaccine Efficacy Study Successfully Achieved Its Primary Clinical Endpoint

SANOFI : Sanofi Reaches New Milestone in Fight Against Malaria: 300 million ASAQ Treatments Delivered in Africa

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...

Sanofi: Genzyme to Resubmit Lemtrada Application for FDA Review

Sanofi Appoints Dr. Anne C. Beal to the Newly Created Position of Chief Patient Officer

SANOFI : Sanofi and Regeneron To Present Alirocumab Clinical Data at American College of Cardiology 63rd Annual Scientific Session

SANOFI : Sanofi Pasteur Allies with SK Chemical Co. of South Korea on Pneumococcal Conjugate Vaccine

Sanofi and UCB Partner for Breakthrough Innovation in Immune-mediated Diseases

Sanofi :Filing of the 2013 U.S. Form 20-F and French "Document de Référence" containing the Annual Financial Report

Sanofi's Board of Directors Propose Appointment of Patrick Kron as New Independent Director

SANOFI PASTEUR :Inactivated Polio Vaccines Broadly Available for the World's Children in the Drive toward Polio Eradication

SANOFI : Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the...

SANOFI :Merial announces EU approval for NexGard® First and only monthly beef-flavored chew for fleas and ticks in dogs

"India's vast polio achievement is a call for action for all of us" says Sanofi Pasteur CEO

Sanofi Returns to Growth in Q4 2013

Sanofi Files Suit in The U.S. To Defend Its Patent Rights on Lantus® and Lantus® SoloStar®

INVITATION: Sanofi Annual Results - February 6, 2014

RobecoSAM Includes Sanofi in "Silver Class" of its 2014 Sustainability Yearbook

Sanofi and Transgene Launch Construction Phase of New State-of-the-art Bioproduction Platform

Sanofi Celebrates 50th Anniversary of France - China Relations

Sanofi and MAbImprove LabEx (Tours) Join Forces on Treatment for Rare Lung Disease

Save the Date: February 6 - Sanofi Full Year Results

Sanofi and Fraunhofer-Gesellschaft Announce the Creation of a Natural Product Center of Excellence

Sanofi and Fraunhofer-Gesellschaft Announce the Creation of a Natural Product Center of Excellence

Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases

Sanofi To Expand Access to Clinical Trial Data